Published in Semin Cancer Biol on March 26, 2008
Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov (2011) 2.45
Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal (2009) 2.33
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol (2011) 2.24
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med (2009) 2.13
Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity (2010) 2.08
Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget (2012) 1.77
The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet (2008) 1.60
Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer (2010) 1.54
Hybrid models of tumor growth. Wiley Interdiscip Rev Syst Biol Med (2010) 1.52
Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem (2010) 1.49
Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm (2011) 1.42
Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) (2011) 1.35
Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet (2010) 1.34
Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol (2010) 1.32
Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Res (2011) 1.26
Cancer biomarker discovery: the entropic hallmark. PLoS One (2010) 1.26
Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. J Clin Invest (2012) 1.25
STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A (2012) 1.23
Reduction of metastasis using a non-volatile buffer. Clin Exp Metastasis (2011) 1.21
The calcium-permeable non-selective cation channel TRPM2 is modulated by cellular acidification. J Physiol (2010) 1.18
Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. Front Physiol (2014) 1.11
Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors. Phytochem Rev (2009) 1.08
Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer (2017) 1.07
Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS One (2011) 1.03
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol (2015) 1.01
Dual role of CO2/HCO3(-) buffer in the regulation of intracellular pH of three-dimensional tumor growths. J Biol Chem (2011) 0.99
Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. BMC Cancer (2011) 0.97
The chemistry, physiology and pathology of pH in cancer. Philos Trans R Soc Lond B Biol Sci (2014) 0.94
Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res (2015) 0.94
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells. Cancer Inform (2015) 0.94
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer. Breast Cancer Res (2011) 0.93
What can ecology teach us about cancer? Transl Oncol (2011) 0.93
Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer. Cancer Prev Res (Phila) (2014) 0.92
Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. Am J Physiol Heart Circ Physiol (2011) 0.91
Preventive evolutionary medicine of cancers. Evol Appl (2012) 0.91
Aberrant methylation and associated transcriptional mobilization of Alu elements contributes to genomic instability in hypoxia. J Cell Mol Med (2010) 0.91
Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model. Cancer Res (2011) 0.89
Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures. Proteome Sci (2012) 0.88
Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases. Virchows Arch (2010) 0.87
Secretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cells. PLoS One (2011) 0.86
Case report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human cancer patient: complete response in non-Hodgkin's lymphoma after disease progression with rituximab-CHOP. J Bioenerg Biomembr (2012) 0.86
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer. J Cancer Res Clin Oncol (2013) 0.85
Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation. Oncotarget (2016) 0.83
The real face of HIF1α in the tumor process. Cell Cycle (2012) 0.83
Intracellular carbonic anhydrase activity sensitizes cancer cell pH signaling to dynamic changes in CO2 partial pressure. J Biol Chem (2014) 0.82
Can metabolic plasticity be a cause for cancer? Warburg-Waddington legacy revisited. Clin Epigenetics (2011) 0.82
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors. Int J Mol Sci (2015) 0.82
Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers. Curr Med Chem (2014) 0.82
Elucidation of how cancer cells avoid acidosis through comparative transcriptomic data analysis. PLoS One (2013) 0.81
Synthetic approach for unsaturated precursors for parahydrogen induced polarization of choline and its analogs. J Labelled Comp Radiopharm (2013) 0.81
Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers. PLoS One (2013) 0.81
Cancer metabolism: feeding a worm to starve a tumor. Curr Biol (2013) 0.80
HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha. PLoS One (2008) 0.80
Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity). Cancers (Basel) (2011) 0.79
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer. Vaccines (Basel) (2016) 0.79
Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. Int J Oncol (2015) 0.78
Nile Blue-based nanosized pH sensors for simultaneous far-red and near-infrared live bioimaging. J Am Chem Soc (2013) 0.78
Dependence of Relative Expression of NTR1 and EGFR on Cell Density and Extracellular pH in Human Pancreatic Cancer Cell Lines. Cancers (Basel) (2011) 0.78
Pheochromocytoma: The First Metabolic Endocrine Cancer. Clin Cancer Res (2016) 0.78
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells. Oncotarget (2015) 0.78
Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis. Clin Transl Oncol (2012) 0.78
MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Oncotarget (2015) 0.78
Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia. Sci Rep (2016) 0.77
Origin of Cancer: An Information, Energy, and Matter Disease. Front Cell Dev Biol (2016) 0.77
Carbonic anhydrase IX: a hypoxia-controlled "catalyst" of cell migration. Cell Adh Migr (2013) 0.77
Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade. Cancer Biomark (2010) 0.76
Differential functions of C- and N-terminal hepatitis B x protein in liver cells treated with doxorubicin in normoxic or hypoxic condition. PLoS One (2012) 0.76
ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca(2+)/PI3-kinase/AKT signaling pathway. Lab Invest (2016) 0.76
Normoxic accumulation of HIF1α is associated with glutaminolysis. Clin Oral Investig (2016) 0.76
Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma. Oncotarget (2016) 0.75
A mRNA-Responsive G-Quadruplex-Based Drug Release System. Sensors (Basel) (2015) 0.75
Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis. Am J Physiol Cell Physiol (2015) 0.75
Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model. Pharm Res (2015) 0.75
Sirtuins in metabolism, DNA repair and cancer. J Exp Clin Cancer Res (2016) 0.75
Evolutionary emergence of angiogenesis in avascular tumors using a spatial public goods game. PLoS One (2017) 0.75
Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatment. Oncotarget (2017) 0.75
Deletion of lactate dehydrogenase-A in myeloid cells triggers antitumor immunity. Cancer Res (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
On the origin of cancer cells. Science (1956) 49.55
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 24.77
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer (1955) 10.49
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol (1999) 9.32
Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem (1997) 7.67
Angiogenesis. Annu Rev Med (2006) 6.94
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med (1997) 6.86
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A (1993) 6.77
The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol (1919) 6.74
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64
Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol (1996) 5.52
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A (1997) 5.43
Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology (2003) 5.09
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res (1996) 4.98
Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A (1991) 4.84
Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem (1996) 4.72
Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol (2006) 4.71
A microenvironmental model of carcinogenesis. Nat Rev Cancer (2008) 4.40
Tumor dormancy in vivo by prevention of neovascularization. J Exp Med (1972) 4.34
The experimental study of tumor progression: a review. Cancer Res (1954) 4.03
Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res (2006) 3.90
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem (2000) 3.74
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem (2002) 3.50
Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem (2000) 3.02
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol (1986) 2.86
Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci (2003) 2.46
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol (1999) 2.44
Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A (1997) 2.42
Phosphofructokinase and the Pasteur effect. Biochem Biophys Res Commun (1962) 2.35
c-Myc in breast cancer. Endocr Relat Cancer (2000) 2.32
Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A (1988) 2.25
Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res (2001) 2.19
Function of the c-Myc oncogenic transcription factor. Exp Cell Res (1999) 2.11
Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11
An evolutionary model of carcinogenesis. Cancer Res (2003) 2.10
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res (1996) 2.07
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer (2007) 2.00
Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol (2007) 1.94
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr (2007) 1.83
Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci (1999) 1.75
An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A (1999) 1.74
Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ (1996) 1.73
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol (2001) 1.71
APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci U S A (2000) 1.41
Genetic instability in cancer: theory and experiment. Semin Cancer Biol (2005) 1.34
ADENYLATE AS A METABOLIC REGULATOR. EFFECT ON YEAST PHOSPHOFRUCTOKINASE KINETICS. J Biol Chem (1964) 1.33
Clastogenicity of low pH to various cultured mammalian cells. Mutat Res (1992) 1.30
pH and drug resistance in tumors. Drug Resist Updat (2000) 1.24
The redox switch/redox coupling hypothesis. Neurochem Int (2006) 1.22
Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev (2007) 1.19
Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histol Histopathol (2007) 1.15
Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res (1976) 1.14
Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancer. Oncogene (2002) 1.02
Low pH leads to sister-chromatid exchanges and chromosomal aberrations, and its clastogenicity is S-dependent. Mutat Res (1995) 0.95
Mortality and immortality at the cellular level. A review. Biochemistry (Mosc) (1997) 0.93
Metabolic control: a new solution to an old problem. Curr Biol (2000) 0.91
Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia. J Natl Cancer Inst (1994) 0.90
Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer. Semin Oncol (2003) 0.87
Causes and consequences of increased glucose metabolism of cancers. J Nucl Med (2008) 3.79
Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer (2009) 3.49
Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res (2009) 3.40
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer (2012) 2.71
pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag (2004) 2.68
Radiomics: the process and the challenges. Magn Reson Imaging (2012) 2.65
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res (2009) 1.92
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr (2007) 1.83
A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biol Direct (2010) 1.69
Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev (2007) 1.68
Beyond mammography: new frontiers in breast cancer screening. Am J Med (2013) 1.61
Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol (2006) 1.59
Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res (2009) 1.53
Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp Metastasis (2008) 1.44
Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges". Int J Cancer (2014) 1.44
Automated Delineation of Lung Tumors from CT Images Using a Single Click Ensemble Segmentation Approach. Pattern Recognit (2013) 1.36
Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions. PLoS One (2011) 1.36
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol (2012) 1.28
Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia (2008) 1.23
The role of acidity in solid tumour growth and invasion. J Theor Biol (2005) 1.23
Exploiting evolution to treat drug resistance: combination therapy and the double bind. Mol Pharm (2012) 1.22
Reduction of metastasis using a non-volatile buffer. Clin Exp Metastasis (2011) 1.21
Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med (2013) 1.19
Evolutionary approaches to prolong progression-free survival in breast cancer. Cancer Res (2012) 1.19
Life history trade-offs in cancer evolution. Nat Rev Cancer (2013) 1.16
Proton dynamics in cancer. J Transl Med (2010) 1.14
Evolutionary dynamics in cancer therapy. Mol Pharm (2011) 1.03
Minimization of thermodynamic costs in cancer cell invasion. Proc Natl Acad Sci U S A (2013) 0.98
Test-retest reproducibility analysis of lung CT image features. J Digit Imaging (2014) 0.98
A mathematical model of tumour and blood pHe regulation: The HCO3-/CO2 buffering system. Math Biosci (2010) 0.97
Molecular and functional imaging of breast cancer. Cancer Control (2010) 0.96
Information dynamics in living systems: prokaryotes, eukaryotes, and cancer. PLoS One (2011) 0.95
Order in a multidimensional system. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.95
Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model. J Cancer Sci Ther (2011) 0.94
Tumour-stromal interactions in acid-mediated invasion: a mathematical model. J Theor Biol (2010) 0.94
A quantitative theoretical model for the development of malignancy in ductal carcinoma in situ. J Theor Biol (2009) 0.94
Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. J Infect Dis (2011) 0.89
Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model. Cancer Res (2011) 0.89
Optimization of synchronization in complex clustered networks. Chaos (2008) 0.88
Episodic, transient systemic acidosis delays evolution of the malignant phenotype: Possible mechanism for cancer prevention by increased physical activity. Biol Direct (2010) 0.88
Mathematical modelling of tumour acidity. J Theor Biol (2008) 0.88
Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer (2012) 0.87
Vascular measurements correlate with estrogen receptor status. BMC Cancer (2014) 0.87
Riparian ecosystems in human cancers. Evol Appl (2012) 0.85
Tumor evolution in space: the effects of competition colonization tradeoffs on tumor invasion dynamics. Front Oncol (2013) 0.85
Power laws of complex systems from extreme physical information. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.84
Cancer treatment as a game: integrating evolutionary game theory into the optimal control of chemotherapy. Phys Biol (2012) 0.84
Assessing radiology resident preparedness to manage IV contrast media reactions using simulation technology. Stud Health Technol Inform (2009) 0.82
Cell development obeys maximum Fisher information. Front Biosci (Elite Ed) (2013) 0.82
A unifying theory of carcinogenesis, and why targeted therapy doesn't work. Eur J Radiol (2012) 0.82
Metabolism and its sequelae in cancer evolution and therapy. Cancer J (2015) 0.81
Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance. Womens Health (Lond Engl) (2014) 0.81
The ecology of human papillomavirus-induced epithelial lesions and the role of somatic evolution in their progression. J Infect Dis (2013) 0.78
Modelling a new angle on understanding cancer. Nature (2002) 0.78
Principle of maximum Fisher information from Hardy's axioms applied to statistical systems. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.78
Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma. Mol Pharm (2011) 0.77
Pathology to enhance precision medicine in oncology: lessons from landscape ecology. Adv Anat Pathol (2015) 0.77
Integrated imaging of cancer metabolism. Acad Radiol (2011) 0.77
Alternating synchronizability of complex clustered networks with regular local structure. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.76
Stem Cell Plasticity And Niche Dynamics in Cancer Progression. IEEE Trans Biomed Eng (2016) 0.75
Commentary on a paper by Verbeni et al. Phys Life Rev (2013) 0.75
Leaky vessels as a potential source of stromal acidification in tumours. J Theor Biol (2010) 0.75
Aggregation Effects and Population-based dynamics as a source of therapy resistance in cancer. IEEE Trans Biomed Eng (2016) 0.75
Cancer suppression by compression. Bull Math Biol (2014) 0.75
Conditions for correspondence between Hartree scattering and biological growth. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.75
Dynamics-based scalability of complex networks. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.75
Aggregation Effects and Population-based dynamics as a source of therapy resistance in cancer. IEEE Trans Biomed Eng (2016) 0.75
Erratum to: microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy. Cancer Metastasis Rev (2015) 0.75